Tru Independence LLC Acquires 85 Shares of Johnson & Johnson (NYSE:JNJ)
Tru Independence LLC Acquires 85 Shares of Johnson & Johnson (NYSE:JNJ)
tru Independence LLC raised its holdings in Johnson & Johnson (NYSE:JNJ – Get Rating) by 0.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,816 shares of the company's stock after buying an additional 85 shares during the quarter. tru Independence LLC's holdings in Johnson & Johnson were worth $4,543,000 at the end of the most recent quarter.
據特魯獨立有限責任公司在最近提交給美國證券交易委員會的13F文件中稱，該公司在第三季度將其在強生(紐約證券交易所代碼：JNJ-GET評級)的持股增加了0.3%。該基金持有27,816股該公司股票，該基金在本季度又購買了85股。截至最近一個季度末，Tru獨立有限責任公司持有的強生股份價值4,543,000美元。
A number of other large investors have also recently made changes to their positions in JNJ. DORCHESTER WEALTH MANAGEMENT Co boosted its position in shares of Johnson & Johnson by 8.6% during the first quarter. DORCHESTER WEALTH MANAGEMENT Co now owns 67,618 shares of the company's stock valued at $14,975,000 after purchasing an additional 5,327 shares in the last quarter. Cantor Fitzgerald Investment Advisor L.P boosted its position in shares of Johnson & Johnson by 88.9% during the first quarter. Cantor Fitzgerald Investment Advisor L.P now owns 175,194 shares of the company's stock valued at $31,049,000 after purchasing an additional 82,429 shares in the last quarter. AMI Investment Management Inc. boosted its position in shares of Johnson & Johnson by 8.8% during the first quarter. AMI Investment Management Inc. now owns 18,305 shares of the company's stock valued at $3,244,000 after purchasing an additional 1,475 shares in the last quarter. Equitable Holdings Inc. boosted its position in shares of Johnson & Johnson by 4.9% during the first quarter. Equitable Holdings Inc. now owns 45,673 shares of the company's stock valued at $8,095,000 after purchasing an additional 2,119 shares in the last quarter. Finally, USS Investment Management Ltd boosted its position in shares of Johnson & Johnson by 2.4% during the first quarter. USS Investment Management Ltd now owns 860,371 shares of the company's stock valued at $152,488,000 after purchasing an additional 20,528 shares in the last quarter. 67.94% of the stock is currently owned by institutional investors.
其他一些大型投資者最近也調整了他們在JNJ的倉位。今年第一季度，多切斯特財富管理公司將其持有的強生股票的倉位提高了8.6%。多切斯特財富管理公司目前擁有67,618股該公司股票，價值14,975,000美元，此前該公司在上個季度又購買了5,327股。第一季度，康託菲茨傑拉德投資顧問公司將其持有的強生股票倉位提高了88.9%。Cantor Fitzgerald Investment Advisor L.P在上個季度額外購買了82,429股後，現在擁有175,194股該公司股票，價值31,049,000美元。今年第一季度，阿美投資管理公司將其持有的強生股票頭寸提高了8.8%。阿美投資管理公司目前持有18,305股該公司股票，價值3,244,000美元，該公司在上個季度又購買了1,475股。今年第一季度，公平控股公司將其持有的強生股票頭寸提高了4.9%。Equity Holdings Inc.在上個季度又購買了2,119股後，現在持有45,673股該公司股票，價值8,095,000美元。最後，USS投資管理有限公司在第一季度將其持有的強生股票的頭寸提高了2.4%。USS投資管理有限公司在上個季度額外購買了20,528股後，現在擁有860,371股該公司的股票，價值152,488,000美元。67.94%的股票目前由機構投資者持有。
Insider Activity at Johnson & Johnson
強生的內幕活動
In related news, EVP Jennifer L. Taubert sold 76,923 shares of the company's stock in a transaction on Tuesday, November 22nd. The stock was sold at an average price of $176.78, for a total transaction of $13,598,447.94. Following the completion of the sale, the executive vice president now owns 126,456 shares in the company, valued at $22,354,891.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Johnson & Johnson news, CFO Joseph J. Wolk sold 14,781 shares of the business's stock in a transaction dated Tuesday, December 13th. The stock was sold at an average price of $179.60, for a total transaction of $2,654,667.60. Following the completion of the sale, the chief financial officer now owns 35,812 shares of the company's stock, valued at $6,431,835.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Jennifer L. Taubert sold 76,923 shares of the business's stock in a transaction dated Tuesday, November 22nd. The shares were sold at an average price of $176.78, for a total value of $13,598,447.94. Following the sale, the executive vice president now directly owns 126,456 shares of the company's stock, valued at approximately $22,354,891.68. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 233,611 shares of company stock worth $40,960,735. 0.35% of the stock is owned by insiders.
在相關新聞中，執行副總裁詹妮弗·L·陶伯特在11月22日(星期二)的一筆交易中出售了76,923股該公司股票。股票以176.78美元的平均價格出售，總成交金額為13,598,447.94美元。出售完成後，執行副總裁總裁現在擁有該公司126,456股股份，價值22,354,891.68美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可以通過此超鏈接。在強生的另一則消息中，首席財務官約瑟夫·沃爾克在12月13日(星期二)的交易中出售了14,781股該公司的股票。該股以179.60美元的平均價格出售，總成交金額為2654,667.60美元。出售完成後，首席財務官現在擁有該公司35,812股股票，價值6,431,835.20美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過美國證券交易委員會網站。此外，執行副總裁詹妮弗·L·陶伯特在11月22日星期二的交易中出售了76,923股該公司股票。這些股票的平均價格為176.78美元，總價值為13,598,447.94美元。出售後，執行副總裁總裁現在直接持有該公司126,456股股票，價值約22,354,891.68美元。關於這次銷售的披露可以找到這裏。在過去的90天裏，內部人士賣出了233,611股公司股票，價值40,960,735美元。該公司0.35%的股份由內部人士持有。
Johnson & Johnson Stock Down 0.4 %
強生股價下跌0.4%
Johnson & Johnson (NYSE:JNJ – Get Rating) last posted its quarterly earnings results on Tuesday, January 24th. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.13. The firm had revenue of $23.71 billion during the quarter, compared to analysts' expectations of $23.90 billion. Johnson & Johnson had a return on equity of 35.94% and a net margin of 18.90%. The company's revenue was down 4.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.13 earnings per share. Equities analysts forecast that Johnson & Johnson will post 10.52 earnings per share for the current fiscal year.
強生(紐約證券交易所代碼：JNJ-GET Rating)最近一次公佈季度收益報告是在1月24日，星期二。該公司公佈本季度每股收益為2.35美元，比普遍預期的2.22美元高出0.13美元。該公司本季度營收為237.1億美元，高於分析師預期的239億美元。強生的股本回報率為35.94%，淨利潤率為18.90%。該公司的收入同比下降了4.4%。去年同一季度，該業務每股收益為2.13美元。股票分析師預測，強生本財年每股收益將達到10.52歐元。
Johnson & Johnson Dividend Announcement
強生分紅公告
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 7th. Investors of record on Tuesday, February 21st will be given a dividend of $1.13 per share. This represents a $4.52 dividend on an annualized basis and a yield of 2.69%. The ex-dividend date is Friday, February 17th. Johnson & Johnson's dividend payout ratio (DPR) is presently 67.06%.
該公司最近還披露了季度股息，將於3月7日(星期二)支付。2月21日(星期二)登記在冊的投資者將獲得每股1.13美元的股息。這意味着年化股息為4.52美元，收益率為2.69%。除息日期為2月17日星期五。強生目前的股息支付率為67.06%。
Analyst Ratings Changes
分析師評級發生變化
Several equities research analysts recently weighed in on the company. Credit Suisse Group assumed coverage on Johnson & Johnson in a research report on Thursday, November 17th. They set a "neutral" rating and a $170.00 price target on the stock. Sanford C. Bernstein dropped their target price on Johnson & Johnson from $194.00 to $190.00 in a report on Wednesday, October 19th. Morgan Stanley boosted their target price on Johnson & Johnson from $176.00 to $180.00 and gave the stock an "equal weight" rating in a report on Wednesday. SVB Leerink dropped their target price on Johnson & Johnson from $194.00 to $186.00 and set an "outperform" rating on the stock in a report on Friday, January 20th. Finally, Barclays started coverage on Johnson & Johnson in a report on Monday, October 17th. They issued an "equal weight" rating and a $175.00 target price on the stock. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Johnson & Johnson has a consensus rating of "Moderate Buy" and an average target price of $182.75.
幾位股票研究分析師最近對該公司進行了分析。瑞士信貸集團在11月17日星期四的一份研究報告中對強生進行了報道。他們為該股設定了“中性”評級和170.00美元的目標價。桑福德·伯恩斯坦在10月19日星期三的一份報告中將強生的目標價從194.00美元下調至190.00美元。摩根士丹利在週三的一份報告中將強生的目標價從176.00美元上調至180.00美元，並給予該股“同等權重”的評級。SVB Leerink在1月20日(星期五)的一份報告中將強生的目標價從194.00美元下調至186.00美元，並對該股設定了“跑贏大盤”的評級。最後，巴克萊在10月17日星期一的一份報告中開始了對強生的報道。他們對該股給予了“同等權重”的評級和175.00美元的目標價。7名股票研究分析師對該股的評級為持有，5名分析師給予了買入評級，一名分析師給予了該公司強烈的買入評級。根據MarketBeat.com的數據，強生的共識評級為“適度買入”，平均目標價為182.75美元。
About Johnson & Johnson
關於強生
(Get Rating)
(獲取評級)
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets.
強生是一家控股公司，從事醫療保健領域產品的研發、製造和銷售。它通過以下細分市場運作：消費者健康、製藥和醫療設備。消費者健康部分包括用於嬰兒護理、口腔護理、美容、非處方藥、婦女健康和傷口護理市場的產品。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
- 免費獲取斯托克新聞網關於強生(JNJ)的研究報告
- 市場回顧周-1/23-1/27
- 為什麼Lucid在一天內飆升了近100%
- 利用這些鐵路股票實現增長和收入
- ASML預計今年芯片需求回升，提振銷售觀點
- KLA公司：在動盪不安的半市場中站穩腳跟
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Get Rating).
想看看其他對衝基金持有JNJ的是什麼嗎？訪問HoldingsChannel.com獲取強生(紐約證券交易所代碼：JNJ-GET Rating)的最新13F文件和內幕交易信息。
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
接受《強生日報》的新聞和評級-在下面輸入您的電子郵件地址，即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對強生及相關公司的最新新聞和分析師評級的每日摘要。